Annals of SurgeryBeenken SW,Grizzle WE,Crowe DR,et al.Molecular biomarkers for breast cancer prognosis: coexpression of c-erbB-2 and P53. Annals of Surgery . 2001Molecular Biomarkers for Breast Cancer Prognosis: Coexpression of c-erbB-2 and p53[J] . Samuel W. Beenken,William...
The most common site of metastasis in breast cancer is the bone, where the balance between osteoclast-mediated bone resorption and osteoblast-mediated bone formation is disrupted. This imbalance causes osteolytic bone metastasis in breast cancer, which leads to bone pain, pathological fractures, spinal...
However, when singly analysed, their prognostic relevance was modest, and the only clinically useful biomarkers that remained are cell proliferation and plasminogen activationrelated factors for prognosis, steroid hormone receptors and HER2/neu for prediction of response to hormonal or to the novel ...
The most common site of metastasis in breast cancer is the bone, where the balance between osteoclast-mediated bone resorption and osteoblast-mediated bone formation is disrupted. This imbalance causes osteolytic bone metastasis in breast cancer, which l
High expression of miR-17-5p in tumor epithelium is a predictor for poor prognosis for prostate cancer patients Article Open access 05 July 2021 Evaluation of tumorigenesis-related miRNAs in breast cancer in Egyptian women: a retrospective, exploratory analysis Article Open access 29 November 202...
Triple-negative breast cancer: promising prognostic biomarkers currently in development Introduction: Triple-negative breast cancer (TNBC) is an aggressive type of breast cancer associated with poor prognosis and limited treatment options. Val... J Sukumar,K Gast,D Quiroga,... - 《Expert Review of...
of breast cancer the histologic grade and the alpha-estrogen receptor (ER), progesterone receptor, Ki-67 and HER2 status, in order to assist prognosis and establish therapeutic options, including hormone therapy, chemotherapy and anti-HER2 therapy. One of the four available genetic prognostic ...
Breast cancer is a healthcare concern of women worldwide. Despite procedures being available for diagnosis, prognosis and treatment of breast cancer, researchers are working intensively on the disease in order to improve the life quality of breast cancer patients. At present, there is no single tr...
of peripheral blood circulating nucleic acids such as DNA, mRNA and micro (mi)RNA in breast cancer diagnosis, prognosis and for monitoring response to anticancer therapy. Among these, circulating miRNA is increasingly recognized as a promising biomarker, given the ease with which miRNAs can be ...
Using PathFinder, we discovered that spatial distribution of necrosis in liver cancer, a long-neglected factor, has a strong relationship with patient prognosis. We therefore proposed two clinically independent indicators, including necrosis area fraction and tumour necrosis distribution, for practical ...